Neoleukin Therapeutics, Inc. NLTX
3.49 +3.49
Day range unavailable
52-week range unavailable
Revenue & Expenses
Latest period ending Dec 31, 2022 · select a line to chart its full history
Annual income statement
| Fiscal year | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 |
|---|---|---|---|---|---|
| 59.10M | 60.70M | 33.73M | 70.96M | 57.62M | |
| 41.13M | 39.16M | 24.34M | 4.42M | 41.79M | |
| 17.97M | 21.54M | 17.21M | 18.83M | 15.84M | |
| -59.10M | -60.70M | -33.73M | -70.96M | -32.62M | |
| -57.56M | -60.69M | -33.28M | -69.44M | -31.59M | |
| -57.56M | -60.69M | -33.28M | -69.44M | -31.59M | |
| -57.56M | -60.69M | -33.28M | -69.44M | -31.59M | |
| -57.56M | -60.69M | -33.28M | -69.44M | -31.59M | |
| -1.04 | -1.10 | -0.64 | -2.57 | -1.34 | |
| -1.04 | -1.10 | -0.64 | -2.57 | -1.34 | |
| -1.04 | -1.10 | -0.64 | -2.57 | -1.34 | |
| -57.56M | -60.69M | -33.28M | -69.44M | -31.58M | |
| -57.56M | -60.69M | -33.28M | -69.44M | -31.58M | |
| 55.22M | 55.04M | 51.83M | 27.03M | 23.52M | |
| 55.22M | 55.04M | 51.83M | 27.03M | 23.52M |